The Week in Review: July 6 – July 20, 2018

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.

Friday, July 20, 2018

News Recap:

Zepatier Plus Sovaldi Beats Hep C in Those with Cirrhosis and Genotype 3. Merck’s Zepatier (grazoprevir/elbasvir) plus Gilead Sciences’ Sovaldi (sofosbuvir), with or without ribavirin, cured HCV genotype 3 at high rates in a recent trial. The results were published in Hepatology.

Dirty Ottawa clinic equipment may have affected 4,600 patients. Thousands of people who underwent minor surgery at a west Ottawa medical clinic were at a higher risk of infection due to improperly cleaned medical equipment over the last 15 years, health officials say.